Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Affective forecasting and scope sensitivity of warm glow - Comparisons between joint and separate evaluations.

Acta psychologica·2026
Same author

Nudging provider adoption of clinical decision support: study protocol for a stepped-wedge cluster randomized, hybrid type III trial of an electronic health record-agnostic pulmonary embolism risk tool.

Implementation science : IS·2026
Same author

The development of the social isolation risk scale (SIRS) to identify risk for social isolation in head and neck cancer survivors.

Frontiers in aging·2026
Same author

Pretest-posttest trial of a lung cancer screening decision aid for individuals with multimorbidity from a primary care population.

PEC innovation·2026
Same author

Using Numerical Comparisons to Help Patients Make Choices.

JAMA·2026
Same author

Do radon risk maps encourage residential testing behaviour? Evidence from an experimental study in Canada.

Public health·2025
Same journal

Real-world effectiveness of chemotherapy regimens after immunotherapy in patients with advanced melanoma in Spain: Results from the GEM1801 study.

Cancer·2026
Same journal

Bendamustine in indolent lymphoma: Letting the dust settle down.

Cancer·2026
Same journal

Top advances of the year: Bispecific antibodies in early lines of therapy in multiple myeloma.

Cancer·2026
Same journal

Direct oral anticoagulants and warfarin in atrial fibrillation patients with cancer by anticoagulation quality.

Cancer·2026
Same journal

Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States.

Cancer·2026
Same journal

Toward exercise as standard care for older cancer survivors.

Cancer·2026
See all related articles

Related Experiment Video

Updated: Jun 27, 2026

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Age differences in dual information-processing modes: implications for cancer decision making.

Ellen Peters1, Michael A Diefenbach, Thomas M Hess

  • 1Decision Research, Eugene, Oregon, USA. empeters@decisionresearch.org

Cancer
|December 6, 2008
PubMed
Summary
This summary is machine-generated.

Older adults may face challenges with complex cancer decisions due to declining deliberative processes. However, their focus on emotional goals and experience can improve decision-making quality.

Related Experiment Videos

Last Updated: Jun 27, 2026

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry
06:51

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

Area of Science:

  • Gerontology
  • Cognitive Psychology
  • Health Decision Making

Background:

  • Cancer disproportionately affects older adults, necessitating an understanding of their decision-making processes.
  • Age-related changes in cognitive functions, such as deliberative and affective processes, can impact health choices.

Purpose of the Study:

  • To examine age differences in affective and deliberative information processing relevant to cancer decisions.
  • To review existing evidence on age and decision-making quality.
  • To apply dual-process theories to cancer decision-making in older adults.

Main Methods:

  • Literature review of studies on age differences in affective and deliberative processes.
  • Synthesis of evidence on age-related decision-making.
  • Theoretical application of dual-process models to cancer scenarios.

Main Results:

  • Declines in deliberative processing efficiency with age can lead to poorer decisions, especially with unfamiliar or numeric information.
  • Adaptive age-related processes, like prioritizing emotional goals and leveraging experience, may mitigate these declines.
  • Evidence on direct age differences in decision-making quality remains limited.

Conclusions:

  • Understanding the interplay of affective and deliberative processes is crucial for supporting cancer decision-making in aging populations.
  • Interventions should consider both cognitive declines and adaptive strengths in older adults.
  • Improved understanding can enhance self-help strategies for older adults facing cancer.